Loading...
•
Dec 31, 2020
Cardlytics Q4 2020 Earnings Report
Cardlytics' Q4 2020 financial results showed a slight decrease in revenue compared to the previous year, but exceeded prior guidance. The company reported a net loss and a decrease in billings, but saw an increase in average FI MAUs.
Key Takeaways
Cardlytics announced its Q4 2020 financial results, with total revenue decreasing by 3.2% to $67.1 million compared to Q4 2019. The company reported a net loss attributable to common stockholders of $(6.8) million, or $(0.24) per diluted share, and a non-GAAP net loss of $(1.5) million, or $(0.05) per diluted share. Average FI MAUs increased by 22.6% to 163.6 million, while ARPU decreased by 21.2% to $0.41.
Total revenue decreased by 3.2% to $67.1 million compared to Q4 2019.
Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share.
Non-GAAP net loss was $(1.5) million, or $(0.05) per diluted share.
Average FI MAUs increased by 22.6% to 163.6 million, while ARPU decreased by 21.2% to $0.41.
Cardlytics
Cardlytics
Forward Guidance
Cardlytics anticipates billings, revenue, and adjusted contribution to be in the following ranges (in millions):
Positive Outlook
- Q1 2021 Billings: $67.0 - $75.0 million
- Q1 2021 Revenue: $47.0 - $53.0 million
- Q1 2021 Adjusted contribution: $20.0 - $24.0 million
- FY 2021 Billings: $360.0 - $400.0 million
- FY 2021 Revenue: $250.0 - $275.0 million